Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × Hydroxyethyl Starch Derivatives × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 1 Prostatic Neoplasms 1 Kidney Neoplasms 1 Diverticulitis 1 Crohn Disease 1 Colonic Polyps 1 Colonic Neoplasms 1 Colitis, Ulcerative 1

Interventions

aldesleukin 38 Sunitinib 34 Cyclophosphamide 27 Nivolumab 26 pembrolizumab 25 Interferon-alpha 25 Everolimus 24 Bevacizumab 19 fludarabine phosphate 18 Sorafenib 18 Interleukin-2 17 Peripheral Blood Stem Cell Transplantation 15 Ipilimumab 15 Gemcitabine 14 Filgrastim 14 cabozantinib 13 Axitinib 13 Radiotherapy 12 temsirolimus 10 fludarabine 10 Radiosurgery 10 Doxorubicin 9 Carboplatin 9 sargramostim 8 belzutifan 8 Fluorouracil 8 Etoposide 8 Chemotherapy, Adjuvant 8 Magnetic Resonance Spectroscopy 7 Gene Expression Profiling 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01486550 2014-10-09

VONE

Regional Hospital Holstebro

Phase 4 Terminated

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡